Expedited Programs

Expedited programs are processes used by regulatory agencies, like the FDA, to review and approve new medical products more quickly than usual. They are designed for therapies that address serious or life-threatening conditions and have the potential to offer significant benefits over existing treatments. These programs help patients gain faster access to innovative medicines while still maintaining safety and effectiveness standards. Overall, they streamline the approval process without compromising the integrity of the evaluation.